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Abstract
Hereditary defects in the transcription-coupled nucleotide excision repair (TC-NER) pathway of damaged DNA cause severe
neurodegenerative disease Cockayne syndrome (CS), however the origin and chemical nature of the underlying DNA
damage had remained unknown. To find out, to which degree the structural properties of DNA lesions determine the extent
of transcription arrest in human CS cells, we performed quantitative host cell reactivation analyses of expression vectors
containing various synthetic adducts. We found that a single 3-(deoxyguanosin-N2-yl)-2-acetylaminofluorene adduct
(dG(N2)-AAF) constitutes an unsurmountable obstacle to transcription in both CS-A and CS-B cells and is removed
exclusively by the CSA- and CSB-dependent pathway. In contrast, contribution of the CS proteins to the removal of two
other transcription-blocking DNA lesions – N-(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG(C8)-AAF) and cyclobutane
thymine-thymine (TT) dimer – is only minor (TT dimer) or none (dG(C8)-AAF). The unique properties of dG(N2)-AAF identify
this adduct as a prototype for a new class of DNA lesions that escape the alternative global genome repair and could be
critical for the CS pathogenesis.
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Introduction
Cockayne syndrome (CS) is an incurable genetic disease
characterized by severe neurological and developmental abnor-
malities, growth failure and pathological changes in multiple
organs [1]. CS has been linked to a defect in the transcription-
coupled nucleotide excision repair pathway (TC-NER), which is
normally initiated by arrest of the elongating RNA polymerase II
(RNAPII) complexes at bulky DNA adducts [2,3]. As a result, CS
patients generally manifest impaired recovery of transcription after
DNA damage induction (such as UV-irradiation), which is a useful
diagnostic criterion for CS [4]. Pathogenic mutations in CS were
mapped to the genes CSB/ERCC6 (about 60% of cases) and CSA/
ERCC8 [5]. In response to UV damage, both gene products
regulate (de-)ubiquitination reactions which are essential for
displacement of the stalled RNAPII [6] – CSB as one of the
initial sensors of the damage-arrested RNAPII [7] and CSA as an
interaction partner of the CRL4 E3 ubiquitin ligase complex [8,9].
However, since organs deep in the body are not exposed to UV,
the nature and origins of DNA damage responsible for CS remain
speculative [10,11].
If the TC-NER defect is crucial for the CS phenotype, there
must exist a DNA lesion that would fulfill the following criteria: (i)
a strong capacity to impede the RNAPII-driven transcription; (ii)
requirement of both CSB and CSA proteins for efficient recovery
of transcription in cells; and (iii) the lack of efficient alternative
repair pathways in the absence of TC-NER. The capacity to arrest
the elongating RNAPII has been demonstrated for a few DNA
modifications, including – besides the UV-induced cyclobutane
pyrimidine dimers and (6–4) photoproducts – the adducts of
chemical carcinogens, such as N-2-acetylaminofluorene (AAF)
[12,13]. AAF forms two types of adducts with guanine bases – N-
(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG(C8)-AAF) and 3-
(deoxyguanosin-N2-yl)-2-acetylaminofluorene (dG(N2)-AAF) – with
remarkably different topologies of the modified DNA duplexes.
The presence of dG(C8)-AAF in DNA results in a large degree of
helical distortion [14] and significant thermodynamic destabiliza-
tion of the duplex which facilitates the damage recognition by
human nucleotide excision repair (NER) factors [15,16]. In
contrast, (dG(N2)-AAF) is accommodated in the minor groove of
the helix, increasing the thermodynamic stability of the duplex
DNA [17]. According to the prevailing bipartite model of the
damage recognition in NER [18], this is expected to impede the
detection of dG(N2)-AAF. Here, we tested whether the strikingly
different thermodynamic properties of the two AAF adducts have
PLOS ONE | www.plosone.org 1 April 2014 | Volume 9 | Issue 4 | e94405
implications for the repair pathway, which led us to finding that
only dG(N2)-AAF requires the CSA and CSB proteins.
Materials and Methods
Oligonucleotides
All synthetic deoxyribo-oligonucleotides were HPLC-purified
and verified by MALDI-TOF mass spectrometry. The sequence
was 59-CATTGCTTCGCTAGCACG, where the underlined TT
and G indicate the positions of the TT dimer and the
acetylaminofluorene (AAF) adducts. Unmodified oligonucleotide
was purchased from Eurofins MWG Operon (Ebersberg, Ger-
many). Oligonucleotide containing TT dimer was from TriLink
BioTechnologies (San Diego, CA). Oligonucleotides containing
the N-(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG(C8)-AAF)
and 3-(deoxyguanosin-N2-yl)-2-acetylaminofluorene (dG(N2)-AAF)
adducts were produced as following.
The dG(C8)-AAF phosphoramidite containing an isopropyl-
phenoxyacetyl group at the N2 position for solid phase DNA
synthesis was prepared as previously published [19,20] and
incorporated into DNA using ultra mild conditions [21]. The
dG(N2)-AAF phosphoramidite for solid phase DNA synthesis was
prepared as previously published by Johnson and coworkers and
incorporated into DNA using standard conditions [22]. Deprotec-
tion and cleavage of the oligodeoxynucleotides from the CPG
carrier containing dG(N2)-AAF were carried out in a mixture of
saturated (7 M) ammonia solution in water:ethanol (3:1) at 17 uC
overnight. Oligonucleotide synthesis was performed on an ABI
394 Nucleic Acid Synthesis System (Life Technologies, Darmstadt,
Germany). Phosphoramidites for dA, dC, dG, dT and CPG
carriers were obtained from Glen Research (Sterling, VA) or Link
Technologies (Bellshill, Scotland). The coupling time for the
modified phosphoramidites was extended to 2 6 7 min.
DNA purification was conducted on analytical and preparative
HPLC (Waters, Eschborn, Germany) using Nucleodur or
Nucleosil columns (250 6 4 mm, C18ec, particle size 3 mm or
250 6 10 mm, C18ec, particle size 5 mm) from Macherey-Nagel
(Düren, Germany). The applied buffer was 0.1 M triethylammo-
nium acetate in water and 0.1 M triethylammonium acetate in an
80% aqueous MeCN buffer system. The fractions were checked
for purity by analytical HPLC. The purified oligonucleotides were
concentrated using a Savant SpeedVac system (Thermo Scientific,
Dreieich, Germany) and desalted with Sep-Pak cartridges (Wa-
ters).
Construction of vectors containing single adducts
Mammalian expression vectors pZAJ-5w-AGC and pZAJ-5c-
AGC, containing the 59-CATTGCTTCGCTAGCACG-
CATTGC sequence in opposite orientations within the the 59
untranslated region (59-UTR) of a gene coding for the enhanced
green fluorescent protein (EGFP), were described previously [23].
A pair of vectors, containing the same sequences in an arbitrarily
chosen non-genic region upstream of the immediate early CMV
promoter, was constructed by analogous procedures from the
same maternal pZAJ vector.
Site-specific double nicks were produced in either the
transcribed or coding DNA strand with the Nb.BsrDI endonucle-
ase (NEB GmbH, Frankfurt am Main, Germany). After melting
the excised 18-mers away, the synthetic oligonucleotides (unmod-
ified or containing the specified adducts) were inserted and the
nicks sealed by the protocol described previously [24]. The
presence of dG(C8)-AAF and dG(N2)-AAF in vector DNA was
verified by the inhibition of generation of a double-stranded break
by the NheI restriction endonuclease; the presence of TT dimer
was verified by incision with T4 endonuclease V (Figure S1).
Cell lines
Immortalised human skin fibroblasts from patients with
mutations in the specified nucleotide excision repair genes were
obtained from the NIGMS Human Genetic Cell Repository,
Coriell Institute for Medical Research (Camden, New Jersey,
USA). The CS-B cell line was CS1ANps3g2 (GM16095); the CS-A
cell line was CS3BEs3gl (GM16094); the XP-A cell line was
XP20S (GM04312); and the XP-C cell line was XP4PA-SV-EB
(GM15983). The matched repair-proficient cell line was MRC-5
VA1 (AG10076). The CSB-corrected cell line was CS1ANps3g2
transfected with the CSB cDNA expression construct [25], kindly
provided by Kiyoji Tanaka (Osaka University, Japan).
CSB protein knockdown
Stable knockdown of the CSB gene in HeLa cells was achieved
exactly as described previously for another gene [23]. For shRNA
targeting of the CSB gene, the specific complimentary oligonucle-
otides containing the BglII- and HindIII-compatible overhangs
were annealed and cloned into the pENTR/pSuper+ vector
(Addgene, Cambridge, MA) downstream of the H1 promoter. The
sequences of oligonucleotides were the following: 59-
GATCCCCGGAAGAAGCAAGGTTGTAATTCAAGAGATT-
ACAACCTTGCTTCTTCCTTTTTGGAAA (forward) and 59-
AGCTTTTCCAAAAAGGAAGAAGCAAGGTTGTAATCTC-
TTGAATTACAACCTTGCTTCTTCCGGG (reverse). The
CSB protein levels in individual clones were monitored by
Western blotting with the A301-345A rabbit polyclonal antibody
(Bethyl Laboratories, Inc., Montgomery, TX) raised against the
amino acid residues 1–50 of human CSB.
Transfections and gene expression analyses
Exponentially growing cells were co-transfected with equal
amounts of one of the EGFP-encoding vectors with an inserted
synthetic oligonucleotide (either unmodified or containing the
specified adducts) and pDsRed-Monomer-N1 vector (Clontech,
Saint-Germain-en-Laye, France). Transfections were performed
with the help of Effectene (QIAGEN, Hilden, Germany). Cells
were fixed 24 hours post transfections, and EGFP expression was
measured in individual cells by flow cytometry, as described in
detail previously [26].
Results
A unique dG(N2)-AAF abolishes gene expression in CS
cells
Our strategy was to construct mammalian expression vectors
carrying unique synthetic DNA base modifications in defined
positions of the reporter EGFP gene [24], followed by quantitative
gene expression analyses in human host cells carrying mutations in
the CSA and CSB genes. We produced synthetic oligonucleotides
containing unique dG(C8)-AAF and dG(N2)-AAF adducts and
inserted them into the specially designed expression vectors, in
various positions (Figure 1, Figure S1). Analogously constructed
vectors containing a single cyclobutane thymine-thymine (TT)
dimer (Figure 1, Figure S1) were used for comparison. In a
human CS-B cell line, we detected a potent inhibition of the gene
expression by dG(N2)-AAF in the transcribed DNA strand of the
EGFP gene, whereas the construct containing dG(C8)-AAF in the
same position was expressed at the same level as control
unmodified DNA (Figure 1). These results indicate that
dG(C8)-AAF is efficiently removed by a CSB-independent repair
A Critical DNA Lesion in Cockayne Syndrome
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pathway, which is in line with a previous report [27]. In contrast,
dG(N2)-AAF can be neither removed nor bypassed in the absence
of the CSB protein, constituting an unconditional roadblock for
the RNAPII transcription. It is interesting to note that the TT
dimer, which is a widely accepted ‘‘golden standard’’ for a
transcription-blocking lesion and a classical substrate for TC-
NER, exhibited a much milder grade of inhibition of the gene
expression than dG(N2)-AAF. We interpret this attenuated effect as
a result of removal of a significant fraction of TT dimers by global
genome NER (GG-NER) – an alternative (CSA-, CSB- and
transcription-independent) pathway initiated by the specific
damage recognition factors XPC-RAD23B and UV-DDB [3,28].
To test whether the inhibitory effect of the dG(N2)-AAF adduct
on the gene expression requires the damage presence within the
transcribed DNA strand, we also analyzed the effects of the same
three adducts positioned in the opposite DNA strand and in a non-
transcribed sequence upstream of the promoter. Only minimal
effects were caused by dG(N2)-AAF and TT dimers in the coding
strand of the gene and none of the adducts could affect the EGFP
expression when located in the upstream non-transcribed region
(Figure 1), thus indicating that a direct interaction of transcrip-
tion complexes with the dG(N2)-AAF adduct is necessary for the
inhibition of the gene expression.
CSB is required for removal of the transcription-blocking
dG(N2)-AAF
To test whether the CSB gene defect is causal for the inhibitory
effect of single dG(N2)-AAF adduct on the gene transcription, we
transfected the same constructs in parallel into the CS-B cell line
(GM16095) and the isogenic cell line stably expressing the CSB
cDNA [25]. The EGFP expression was restored almost completely
in the CSB-complemented cells (Figure 2A, Figure S2),
indicating that a functional CSB gene is required for the efficient
recovery of transcription. To test the effect of CSB in a different
genetic background, we stably knocked down CSB expression in
HeLa cells by permanent transfection with the specific short
hairpin (sh) RNA. This resulted in an approximately 70%
reduction of the CSB protein level (Figure S3), which in turn
hindered transcription of the dG(N2)-AAF-containing expression
construct (Figure 2A, Figure S4), Altogether, the results indicate
that the requirement for CSB is independent from the genetic
background.
TC-NER is indispensable for removal of the transcription-
blocking dG(N2)-AAF
To obtain further information about the relative contributions
of TC-NER and GG-NER to the repair of dG(N2)-AAF, the
expression was analyzed in parallel in the CS-A and CS-B cell
lines (deficient in the TC-NER), an XP-C cell line (deficient in the
GG-NER), and an XP-A cell line (deficient in both the TC-NER
and GG-NER pathways). A fully repair proficient MRC-5 cell line
was used for comparison. In the XP-C cell line, the expression of
the construct containing dG(N2)-AAF in the transcribed DNA
strand was as good as in the control MRC-5 cells, indicating that
the GG-NER defect does not compromise the efficiency of the
adduct removal (Figure 3, Figure S5). In the CS-A and CS-B
cell lines, the strength of the negative effect of the dG(N2)-AAF
adduct on the gene expression was quantitatively the same as in
the XP-A cell line. Since the TC-NER defect was phenotypically
equivalent to the total absence of NER, we conclude that dG(N2)-
AAF in the transcribed DNA strand can only be repaired by the
transcription-coupled pathway.
Figure 1. Effects of single adducts on the EGFP gene expression in the GM16095 (CS-B) cell line. The protein coding sequence (arrow)
and the transcription start (broken arrow) are represented out of scale, along with the adduct position (star) with respect to the transcription unit.
Overlaid fluorescence distribution plots were obtained by flow cytometric analyses of cells transfected with vectors carrying the specified adducts
(amber line) and with the control constructs obtained by incorporation of the unmodified deoxyribo-oligonucleotide (blue line).
doi:10.1371/journal.pone.0094405.g001
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Figure 2. Modulation of the effect of dG(N2)-AAF by CSB. Host cell reactivation of the EGFP expression in pairs of isogenic cell lines with
different CSB expression statuses. Cells were transfected with constructs containing a unique dG(N2)-AAF (amber colors) or dG (blue colors) in the
transcribed strand of the EGFP gene. Cells were selected according to the expression of DsRed as a transfection marker (the gated region shown by
square brackets near the dot density plots) to generate the overlaid fluorescence distribution plots (on the right). (A) The effect of complementation
of the CSB deficiency by expression of the CSB cDNA. (B) The effect of CSB knockdown by expression of the specific shRNA (CSBsh). See also Figures
S3 and S4.
doi:10.1371/journal.pone.0094405.g002
Figure 3. Exclusive requirement of TC-NER for the removal of transcription-blocking dG(N2)-AAF. Host cell reactivation in human cell
lines of the specified nucleotide excision repair complementation groups (CS-A, CS-B, XP-C and XP-A) and in the repair proficient cell line (MRC-5). The
expression constructs contained a unique dG(N2)-AAF or dG in the specified DNA strand. (A) Overlaid fluorescence distribution plots obtained in a
representative experiment. All cell lines were transfected in parallel with the same constructs. (B) Mean relative expression (dG(N2)-AAF/dG) calculated
for multiple transfections with independent preparations of the expression constructs (n = 3, +/2 s.d.).
doi:10.1371/journal.pone.0094405.g003
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Host cell reactivation efficiencies of vectors carrying
various adducts in CS-A cells
Data shown in Figure 3 indicate that the products of CSA and
CSB genes are of the same critical importance for removal of the
transcription-blocking dG(N2)-AAF in cells. We questioned how
harmful are two other bulky DNA lesions – dG(C8)-AAF and TT
dimer – for the gene expression in CS-A cells. Regardless of the
DNA strand concerned, the constructs containing dG(C8)-AAF
and the corresponding adduct-free control vectors were expressed
at the same levels (Figure 4), exactly recapitulating the results
previously obtained in the CS-B cell line (Figure 1). TT dimer
induced inhibition of the gene expression which was milder than in
the case of dG(N2)-AAF and exhibited a less pronounced DNA
strand-specificity, which may indicate some indirect interference of
the lesion with transcription (Figure 4). Both findings resembled
the effects previously observed in the CS-B cell line (Figure 1).
Altogether, of the three lesions investigated, dG(N2)-AAF turned
out to be most critical for transcription both in CS-A and CS-B
cells, if present in the transcribed DNA strand. None of the lesions
could influence the EGFP expression when located in the
upstream non-transcribed region (data not shown).
Discussion
In summary, of the three bona fide transcription blocking DNA
base modifications investigated here, only dG(N2)-AAF constitutes
an insuperable transcription block in human CS cells. Two other
DNA lesions are repaired or bypassed to a significant (TT dimer)
or full (dG(C8)-AAF) extent. The removal of dG(N2)-AAF from the
transcribed DNA strand of the actively transcribed gene takes
place exclusively by the TC-NER pathway which requires both
CSA and CSB proteins, whereas the GG-NER pathway (initiated
by the XPC gene product) is unimportant. This finding explains
the remarkably long (.11 months) persistence time of dG(N2)-
AAF in rats fed with 2-nitrofluorene [29]. In a striking contrast,
the contribution of TC-NER to the removal of another AAF
adduct (dG(C8)-AAF) from the same transcribed gene is negligible,
providing a reason for the absence of a strand-selective repair of
dG(C8)-AAF in the endogenous ADA gene [27].
Comparison between the two AAF adducts suggests that GG-
NER may be generally inefficient for adducts which have minimal
influence on the DNA duplex structure and thermodynamic
stability, leaving TC-NER as the only possible repair pathway.
Such DNA lesions must be especially harmful in the CS-A and
CS-B patients. Thereby, dG(N2)-AAF can be regarded as a close
prototype for unknown DNA lesion(s) that could be responsible for
the molecular pathology of CS. Adducts with similar structural
and thermodynamic features can be formed by active metabolites
of environmental and dietary compounds (such as arylamines and
heterocyclic amines), raising a possibility that manifestation of the
clinical features of CS can be influenced by environmental
exposures and the individual metabolic phenotype. This would
explain the lack of good correlation between the patients’ genotype
and the severity of the disease [5], including the absence of the
characteristic CS phenotype in a few described cases [30,31].
Supporting Information
Figure S1 Verification of the incorporation of oligonu-
cleotides containing the specified adducts into vector
DNA. The presence of acetylaminofluorene adducts (dG(C8)-AAF
or dG(N2)-AAF, indicated by the asterisk in the DNA sequence)
within the unique NheI cleavage sequence (59-GCTAGC) was
verified by inhibition of the NheI endonuclease activity (left panel).
The incorporation of thymine dimer was verified by incision with
T4 endonuclease V (T4 EV) which cleaves the N-glycosylic bond
of the 59 thymine of the dimer and the phosphodiester bond 39 to
the resulting abasic site (right panel). Images show typical vector
preparations analyzed in agarose gels containing ethidium
bromide.
(PDF)
Figure S2 Host cell reactivation of the EGFP expression
in the CS-B cell line and the isogenic cell line corrected
by expression of the CSB cDNA. Transfected constructs
contained a unique dG(N2)-AAF in either the transcribed or non-
transcribed (coding) strand of the EGFP gene, as indicated.
Extended data for the experiment shown in Figure 2a.
(PDF)
Figure S3 Stable knockdown of the endogenous CSB
expression in HeLa cells. Single clones were selected following
transfections with empty vector (no sh) or the vector expressing the
shRNA designed to target the CSB gene (CSBsh, three different
clones) and analyzed by Western blot. Of the two bands
recognized by the CSB antibody, one corresponds to the full-
length CSB protein (arrow). This band is absent in the extracts
obtained from the CS-B cell line (GM16095).
(PDF)
Figure S4 Host cell reactivation of the EGFP expression
in HeLa cells and the derived cell lines with different
CSB expression statuses. Clonal cell lines stably transfected
with empty vector (no sh) or the vector expressing the CSB-specific
shRNA (CSBsh, clone 21) were transfected with constructs
containing a unique dG(N2)-AAF in either the transcribed or
non-transcribed (coding) strand of the EGFP gene, as indicated.
Extended data for the experiment shown in Figure 2b.
(PDF)
Figure S5 Host cell reactivation in human cell lines of
the specified nucleotide excision repair complementa-
tion groups (CS-A, CS-B, XP-C and XP-A) and in the
repair proficient cell line (MRC-5). The expression con-
structs contained synthetic oligonucleotides with a unique dG(N2)-
AAF (amber colors) or dG (blue colors) in the specified DNA
Figure 4. Effects of single adducts on the EGFP gene
expression in the GM16094 (CS-A) cell line. Overlaid fluorescence
distribution plots of cells transfected with vectors carrying the specified
adducts (amber line) and with the control constructs obtained by
incorporation of the unmodified deoxyribo-oligonucleotide (blue line).
doi:10.1371/journal.pone.0094405.g004
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strand. Dot density plots obtained in a representative experiment
and the corresponding overlaid fluorescence distribution plots.
Extended data for the experiment shown in Figure 3.
(PDF)
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